PAR 0.00% 22.5¢ paradigm biopharmaceuticals limited..

Ann: EAP - 65% PAIN REDUCTION IN 10 OA PATIENTS IN USA, page-156

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 132 Posts.
    lightbulb Created with Sketch. 19
    10 patients in a subjective assessment of pain reduction? Wake up you guys! If you need more convincing take a look here: "Placebo-controlled clinical trials are the gold standard in drug development, in part to ensure that the efficacy of a new therapy exceeds the placebo response in the indication being studied. In osteoarthritis (OA), placebo treatment can result in pain reduction, functional improvement and stiffness reduction associated of up to 80% of the observed treatment efficacy. In fact, in randomized controlled trials, improvement perceived by OA patients taking placebo can be so great that some experts have suggested administration of placebo as a treatment option"

    https://www.tools4patient.com/the-placebo-response-in-drug-development-part-2-osteoarthritis/
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.000(0.00%)
Mkt cap ! $78.73M
Open High Low Value Volume
22.0¢ 22.5¢ 22.0¢ $34.69K 154.9K

Buyers (Bids)

No. Vol. Price($)
1 28174 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 25000 1
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.